{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:18:26Z","timestamp":1788722306203,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40263-025-01185-5","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:29:10Z","timestamp":1746206950000},"page":"637-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0641-3917","authenticated-orcid":false,"given":"Seungjoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-7098","authenticated-orcid":false,"given":"Moinay","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-6037","authenticated-orcid":false,"given":"Sae Min","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4474-1295","authenticated-orcid":false,"given":"Min-Yong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5401-5660","authenticated-orcid":false,"given":"Chang-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-8852","authenticated-orcid":false,"given":"Nak-Hoon","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-8615","authenticated-orcid":false,"given":"Jae Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"issue":"21","key":"1185_CR1","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","volume":"386","author":"P Devereaux","year":"2022","unstructured":"Devereaux P, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, et al. Tranexamic acid in patients undergoing noncardiac surgery. N Engl J Med. 2022;386(21):1986\u201397.","journal-title":"N Engl J Med"},{"issue":"15","key":"1185_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1056\/NEJMoa2207419","volume":"388","author":"LD Pacheco","year":"2023","unstructured":"Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM Jr, et al. Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery. N Engl J Med. 2023;388(15):1365\u201375. https:\/\/doi.org\/10.1056\/NEJMoa2207419.","journal-title":"N Engl J Med"},{"issue":"7","key":"1185_CR3","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, Chou S-Y, Cruz-Flores S, Dangayach NS, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2023;54(7):e314\u201370. https:\/\/doi.org\/10.1161\/STR.0000000000000436.","journal-title":"Stroke"},{"issue":"1","key":"1185_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12028-023-01713-5","volume":"39","author":"MM Treggiari","year":"2023","unstructured":"Treggiari MM, Rabinstein AA, Busl KM, Caylor MM, Citerio G, Deem S, et al. Guidelines for the neurocritical care management of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39(1):1\u201328. https:\/\/doi.org\/10.1007\/s12028-023-01713-5.","journal-title":"Neurocrit Care"},{"issue":"7","key":"1185_CR5","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2022;53(7):e282\u2013361. https:\/\/doi.org\/10.1161\/STR.0000000000000407.","journal-title":"Stroke"},{"issue":"3","key":"1185_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0625","volume":"5","author":"V Karl","year":"2022","unstructured":"Karl V, Thorn S, Mathes T, Hess S, Maegele M. Association of tranexamic acid administration with mortality and thromboembolic events in patients with traumatic injury: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(3): e220625. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.0625.","journal-title":"JAMA Netw Open"},{"issue":"10135","key":"1185_CR7","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","volume":"391","author":"N Sprigg","year":"2018","unstructured":"Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, et al. Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391(10135):2107\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(18)31033-X.","journal-title":"Lancet"},{"issue":"2","key":"1185_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/svn-2021-000941","volume":"6","author":"X Nie","year":"2021","unstructured":"Nie X, Liu J, Liu D, Zhou Q, Duan W, Pu Y, et al. Haemostatic therapy in spontaneous intracerebral haemorrhage patients with high-risk of haematoma expansion by CT marker: a systematic review and meta-analysis of randomised trials. Stroke Vasc Neurol. 2021;6(2):170\u20139. https:\/\/doi.org\/10.1136\/svn-2021-000941.","journal-title":"Stroke Vasc Neurol."},{"issue":"1","key":"1185_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s13054-021-03799-9","volume":"25","author":"S Murao","year":"2021","unstructured":"Murao S, Nakata H, Roberts I, Yamakawa K. Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis. Crit Care. 2021;25(1):380. https:\/\/doi.org\/10.1186\/s13054-021-03799-9.","journal-title":"Crit Care"},{"issue":"1","key":"1185_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13054-016-1322-5","volume":"20","author":"A Wafaisade","year":"2016","unstructured":"Wafaisade A, Lefering R, Bouillon B, Bohmer AB, Gassler M, Ruppert M, et al. Prehospital administration of tranexamic acid in trauma patients. Crit Care. 2016;20(1):143. https:\/\/doi.org\/10.1186\/s13054-016-1322-5.","journal-title":"Crit Care"},{"issue":"1","key":"1185_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11739-022-03155-x","volume":"18","author":"P Dhingra","year":"2023","unstructured":"Dhingra P, Yeung M, Lang E. Tranexamic acid in emergency medicine. An overview of reviews. Intern Emerg Med. 2023;18(1):211\u20138. https:\/\/doi.org\/10.1007\/s11739-022-03155-x.","journal-title":"Intern Emerg Med"},{"issue":"3","key":"1185_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ana.410020310","volume":"2","author":"J van Rossum","year":"1977","unstructured":"van Rossum J, Wintzen AR, Endtz LJ, Schoen JH, de Jonge H. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. Ann Neurol. 1977;2(3):238\u201342. https:\/\/doi.org\/10.1002\/ana.410020310.","journal-title":"Ann Neurol"},{"issue":"6","key":"1185_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ana.410030607","volume":"3","author":"B Chandra","year":"1978","unstructured":"Chandra B. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Ann Neurol. 1978;3(6):502\u20134. https:\/\/doi.org\/10.1002\/ana.410030607.","journal-title":"Ann Neurol"},{"issue":"6118","key":"1185_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/bmj.1.6118.945","volume":"1","author":"RS Maurice-Williams","year":"1978","unstructured":"Maurice-Williams RS. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Br Med J. 1978;1(6118):945\u20137. https:\/\/doi.org\/10.1136\/bmj.1.6118.945.","journal-title":"Br Med J"},{"issue":"5","key":"1185_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/01.str.10.5.519","volume":"10","author":"M Kaste","year":"1979","unstructured":"Kaste M, Ramsay M. Tranexamic acid in subarachnoid haemorrhage. A double-blind study. Stroke. 1979;10(5):519\u201322. https:\/\/doi.org\/10.1161\/01.str.10.5.519.","journal-title":"Stroke"},{"issue":"2","key":"1185_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1227\/00006123-198102000-00004","volume":"8","author":"H Fodstad","year":"1981","unstructured":"Fodstad H, Forssell A, Liliequist B, Schannong M. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery. 1981;8(2):158\u201365. https:\/\/doi.org\/10.1227\/00006123-198102000-00004.","journal-title":"Neurosurgery"},{"issue":"7","key":"1185_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJM198408163110703","volume":"311","author":"M Vermeulen","year":"1984","unstructured":"Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984;311(7):432\u20137. https:\/\/doi.org\/10.1056\/NEJM198408163110703.","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"1185_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01402177","volume":"102","author":"SA Tsementzis","year":"1990","unstructured":"Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir (Wien). 1990;102(1\u20132):1\u201310. https:\/\/doi.org\/10.1007\/BF01402177.","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"1185_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1212\/wnl.54.1.77","volume":"54","author":"Y Roos","year":"2000","unstructured":"Roos Y. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR study group. Neurology. 2000;54(1):77\u201382. https:\/\/doi.org\/10.1212\/wnl.54.1.77.","journal-title":"Neurology"},{"issue":"4","key":"1185_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","volume":"97","author":"J Hillman","year":"2002","unstructured":"Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97(4):771\u20138. https:\/\/doi.org\/10.3171\/jns.2002.97.4.0771.","journal-title":"J Neurosurg"},{"key":"1185_CR21","doi-asserted-by":"publisher","unstructured":"Perel P, Al-Shahi Salman R, Kawahara T, Morris Z, Prieto-Merino D, Roberts I, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury\u2014a nested randomised, placebo-controlled trial. Health Technol Assess. 2012;16(13):iii\u2013xii, 1\u201354. https:\/\/doi.org\/10.3310\/hta16130.","DOI":"10.3310\/hta16130"},{"key":"1185_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-227X-13-20","volume":"13","author":"S Yutthakasemsunt","year":"2013","unstructured":"Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, Thinkamrop B, Phuenpathom N, Lumbiganon P. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med. 2013;13:20. https:\/\/doi.org\/10.1186\/1471-227X-13-20.","journal-title":"BMC Emerg Med"},{"issue":"6","key":"1185_CR23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.007","volume":"23","author":"N Sprigg","year":"2014","unstructured":"Sprigg N, Renton CJ, Dineen RA, Kwong Y, Bath PM. Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461). J Stroke Cerebrovasc Dis. 2014;23(6):1312\u20138. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2013.11.007.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1185_CR24","doi-asserted-by":"publisher","first-page":"e748","DOI":"10.1016\/j.wneu.2017.10.075","volume":"109","author":"E Fakharian","year":"2018","unstructured":"Fakharian E, Abedzadeh-Kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of pemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg. 2018;109:e748\u201353. https:\/\/doi.org\/10.1016\/j.wneu.2017.10.075.","journal-title":"World Neurosurg."},{"issue":"10210","key":"1185_CR25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","volume":"394","author":"I Roberts","year":"2019","unstructured":"Roberts I, Shakur-Still H, Aeron-Thomas A, Belli A, Brenner A, Chaudary MA, et al. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(19)32233-0.","journal-title":"Lancet"},{"issue":"4","key":"1185_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","volume":"45","author":"O Chakroun-Walha","year":"2019","unstructured":"Chakroun-Walha O, Samet A, Jerbi M, Nasri A, Talbi A, Kanoun H, et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients. Eur J Trauma Emerg Surg. 2019;45(4):719\u201326. https:\/\/doi.org\/10.1007\/s00068-018-0974-z.","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"4","key":"1185_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2174\/1574887114666190620112829","volume":"14","author":"P Ebrahimi","year":"2019","unstructured":"Ebrahimi P, Mozafari J, Ilkhchi RB, Hanafi MG, Mousavinejad M. Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial. Rev Recent Clin Trials. 2019;14(4):286\u201391. https:\/\/doi.org\/10.2174\/1574887114666190620112829.","journal-title":"Rev Recent Clin Trials"},{"issue":"12","key":"1185_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","volume":"19","author":"A Meretoja","year":"2020","unstructured":"Meretoja A, Yassi N, Wu TY, Churilov L, Sibolt G, Jeng JS, et al. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2020;19(12):980\u20137. https:\/\/doi.org\/10.1016\/S1474-4422(20)30369-0.","journal-title":"Lancet Neurol"},{"key":"1185_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.34171\/mjiri.34.107","volume":"34","author":"F Mojallal","year":"2020","unstructured":"Mojallal F, Nikooieh M, Hajimaghsoudi M, Baqherabadi M, Jafari M, Esmaeili A, et al. The effect of intravenous tranexamic acid on preventing the progress of cerebral hemorrhage in patients with brain traumatic injuries compared to placebo: a randomized clinical trial. Med J Islam Repub Iran. 2020;34:107. https:\/\/doi.org\/10.34171\/mjiri.34.107.","journal-title":"Med J Islam Repub Iran"},{"issue":"1","key":"1185_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/1574887114666191118111826","volume":"15","author":"M Mousavinejad","year":"2020","unstructured":"Mousavinejad M, Mozafari J, Ilkhchi RB, Hanafi MG, Ebrahimi P. Intravenous tranexamic acid for brain contusion with intraparenchymal hemorrhage: randomized, double-blind, placebo-controlled trial. Rev Recent Clin Trials. 2020;15(1):70\u20135. https:\/\/doi.org\/10.2174\/1574887114666191118111826.","journal-title":"Rev Recent Clin Trials"},{"issue":"10","key":"1185_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jama.2020.8958","volume":"324","author":"SE Rowell","year":"2020","unstructured":"Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, et al. Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA. 2020;324(10):961\u201374. https:\/\/doi.org\/10.1001\/jama.2020.8958.","journal-title":"JAMA"},{"issue":"2","key":"1185_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/svn-2021-000942","volume":"6","author":"J Liu","year":"2021","unstructured":"Liu J, Nie X, Gu H, Zhou Q, Sun H, Tan Y, et al. Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial. Stroke Vasc Neurol. 2021;6(2):160\u20139. https:\/\/doi.org\/10.1136\/svn-2021-000942.","journal-title":"Stroke Vasc Neurol."},{"issue":"10269","key":"1185_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","volume":"397","author":"R Post","year":"2021","unstructured":"Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, et al. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet. 2021;397(10269):112\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)32518-6.","journal-title":"Lancet"},{"issue":"3","key":"1185_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/atr.atr_43_22","volume":"11","author":"E Fakharian","year":"2022","unstructured":"Fakharian E, Abedzadeh-Kalahroudi M, Atoof F, Nooranipour V, Azadbakht J. The impact of tranexamic acid on brain contusion and intraparenchymal hemorrhage in patients with head injury. Arch Trauma Res. 2022;11(3):133\u20139. https:\/\/doi.org\/10.4103\/atr.atr_43_22.","journal-title":"Arch Trauma Res."},{"issue":"9","key":"1185_CR35","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1161\/STROKEAHA.123.042866","volume":"54","author":"AA Polymeris","year":"2023","unstructured":"Polymeris AA, Karwacki GM, Siepen BM, Schaedelin S, Tsakiris DA, Stippich C, et al. Tranexamic acid for intracerebral hemorrhage in patients on non-vitamin K antagonist oral anticoagulants (TICH-NOAC): a multicenter, randomized, placebo-controlled, phase 2 trial. Stroke. 2023;54(9):2223\u201334. https:\/\/doi.org\/10.1161\/STROKEAHA.123.042866.","journal-title":"Stroke"},{"issue":"4","key":"1185_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40263-019-00608-4","volume":"33","author":"W Hu","year":"2019","unstructured":"Hu W, Xin Y, Chen X, Song Z, He Z, Zhao Y. Tranexamic acid in cerebral hemorrhage: a meta-analysis and systematic review. CNS Drugs. 2019;33(4):327\u201336. https:\/\/doi.org\/10.1007\/s40263-019-00608-4.","journal-title":"CNS Drugs"},{"issue":"11","key":"1185_CR37","doi-asserted-by":"publisher","first-page":"CD001245","DOI":"10.1002\/14651858.CD001245.pub3","volume":"11","author":"MR Germans","year":"2022","unstructured":"Germans MR, Dronkers WJ, Baharoglu MI, Post R, Verbaan D, Rinkel GJ, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2022;11(11):CD001245. https:\/\/doi.org\/10.1002\/14651858.CD001245.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"1185_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.761185","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo Y, Guo XM, Li RL, Zhao K, Bao QJ, Yang JC, et al. Tranexamic acid for acute spontaneous intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Front Neurol. 2021;12: 761185. https:\/\/doi.org\/10.3389\/fneur.2021.761185.","journal-title":"Front Neurol"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01185-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:46:48Z","timestamp":1749808008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01185-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01185-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"14 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The meta-analytic dataset was derived from previously published studies, and all included data can be verified through the original publications. The data that support the findings of this study are also available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The code used for this study is available from the corresponding author upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Contributed to the conception and design of the study: J.H.K., M.K., and S.J.L.; performed the title and abstract screening: J.H.K., M.Y.K., and S.M.K.; performed the data extraction: J.H.K., S.M.K., and S.J.L.; organized the data and created the characteristic tables: M.K. and S.J.L.; performed the data analysis: J.H.K. and N.H.S; wrote the first draft of the manuscript: J.H.K. and C.H.K. All authors contributed to manuscript revision, and read and approved the submitted version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}